Mark Genovese

Mark Genovese

Corporate Officer/Principal bij ELI LILLY AND COMPANY
Health Technology
Consumer Services

Profiel

Mark Genovese is currently the Senior Vice President-Immunology Development at Eli Lilly & Co. He previously worked as the Director at Kyverna Therapeutics, Inc. and as the Clinical Chief-Immunology & Rheumatology at Stanford University.
From 2020 to 2023, he served as the Senior Vice President-Inflammation Development at Gilead Sciences, Inc. Dr. Genovese completed his undergraduate degree at the University of Notre Dame and obtained his doctorate from The Johns Hopkins University School of Medicine.

Actieve functies van Mark Genovese

BedrijvenFunctieBegin
ELI LILLY AND COMPANY Corporate Officer/Principal 16-10-2023

Eerdere bekende functies van Mark Genovese

BedrijvenFunctieEinde
GILEAD SCIENCES, INC. Corporate Officer/Principal 01-09-2023
KYVERNA THERAPEUTICS, INC. Directeur/Bestuurslid -
Corporate Officer/Principal -
Ervaring van Mark Genovese in detail bekijken

Opleiding van Mark Genovese

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

21

Eerstegraads connecties

6

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit6

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Mark Genovese